ClinicalTrials.Veeva

Menu

GMA and Peri in Moderate-late Preterms

U

University of Castilla-La Mancha

Status

Unknown

Conditions

Preterm
Cerebral Palsy
Risk Factor
Assessment

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

To analyze the relationship between the early diagnosis of cerebral palsy with the risk factors of this pathology in moderate and late premature infants

Full description

Analyze a sample of moderate and late premature infants using general movements and verify which of them would have an early diagnosis of cerebral palsy and relate it to their risk factors for this pathology.

Enrollment

150 estimated patients

Sex

All

Ages

32 to 36 weeks old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Subjects who were born between the week 32 + 0 days and the week 36 + 6 days and who are admitted to the Hospital Nuestra Señora del Prado de Talavera de la Reina or the Hospital Virgen de la Salud de Toledo.

Exclusion criteria

  • Any type of pre and perinatal diagnostic neurological involvement.

  • Any type of pathology associated with prematurity.

  • Children who have prescribed any of the following medications (10):

    • Barbiturates
    • Antiepileptic
    • Indomethacin
    • Dexamethasone

Trial contacts and locations

1

Loading...

Central trial contact

Javier Merino Andrés, MsC

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems